New Market Report: China Levothyroxine Market, 2010-2019

Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones mainly promote the growth and development of bones, brain and reproductive organs, even the growth hormone (GH) of pipuitary gland can't work. Besides, pipuitary gland will produce less GH if there is a lack of thyroid hormones. Therefore, cretinism is caused by congenital TH deficiency. Cretinism patients featuring stagnated bone growth and short stature, have abnormal proportion of upper body to lower body with upper body being longer than ordinary people.
Levothyroxine is used for the treatment of congenital hypothyroidism (cretinism) and the long-term replacement treatment of hypothyroidism caused by various reasons. It can also be used in the suppressive therapy for simple goiter, chronic lymphatic thyroiditis, the suppressive therapy after thyroid cancer and the hyperthyroidism inhibition test.
Levothyroxine has become the best-selling drug after entering various countries. It develops fast after entering China with annual sales value rising from less than CNY 15 million in 2005 to CNY 63.51 million in 2014 and CAGR during this period reaching up to 17.5%. Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck has the largest share of about 95% for sales value in 2014.
The market size of levothyroxine in China is expected to keep growing in the next few years.

Full Report Details at
- http://www.fastmr.com/prod/1015943_china_levothyroxine_20102019.aspx?afid=301

Readers can get at least the following information from this report:

* market size of levothyroxine in China
* competitive landscape of levothyroxine in Chinese market
* price of levothyroxine made by different enterprises in China
* market outlook of levothyroxine in China

The author suggests the following groups of people purchase this report:

* manufacturers of drugs for regulating endocrine metabolism
* investors/ research institutions interested in Chinese medicine market
* any interest in the Chinese medicine market, please contact CRI for customized survey service

Companies Mentioned in this Report: Merck (Germany), China Associated Pharmaceutical, Berlin-Chemie AG (Germany)

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)